Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 6CNS 6Myeloid 5Genitourinary 4Tumor-Agnostic 3Gynecologic 3Breast 3Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Sarcoma 1NET 1Endocrine 1Dermatologic 1

Conditions

Ovarian Neoplasms 3Melanoma 1Kidney Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phlebotomy × Gynecologic × Clear all
NCT02781272 2023-06-05

EMBER

Angle plc

Completed
200 enrolled
Gynecologic

Ovarian Neoplasms

NCT04154163 2022-02-28

ADOPT

University of Dundee

Completed
18 enrolled
DermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

NCT02785731 2018-11-09

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

Angle plc

Completed
204 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡